DrugsControl Media Services
DrugsControl.org

News Detail

Antibiotic for liver disease patients exposes them to dangerous superbug (31-10-2024)

Melbourne, 31 Oct 2024: An international team of researchers has found that an antibiotic commonly prescribed for patients with liver disease, called rifaximin, has led to the global emergence of an almost untreatable form of the antimicrobial resistant superbug vancomycin-resist......
View Details

Source : The Peter Doherty Institute for Infection and Immunity
liver disease rifaximin antimicrobial resistant superbug vancomycin-resistant enterococcus faecium (VRE) VRE

Related News